about
Nanoscale drug delivery systems and the blood-brain barrierBrain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomaterialOxidative Stress and Nano-Toxicity Induced by TiO2 and ZnO on WAG Cell LineEfficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizersSolvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effectsEfficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.Biodegradable vancomycin-eluting poly[(d,l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection.Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon CancerSilver nanoparticles cause complications in pregnant miceROS generation and DNA damage with photo-inactivation mediated by silver nanoparticles in lung cancer cell line.Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies.Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI.Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.Radiation sterilization of new drug delivery systems.The Use of Anthracyclines for Therapy of CNS Tumors.Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.Cytotoxic Activity of Highly Purified Silver Nanoparticles Sol Against Cells of Human Immune System.Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.Application of nanoparticles on diagnosis and therapy in gliomas.Advancement of wound care from grafts to bioengineered smart skin substitutes.A Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q27026978-3B71F516-D4FD-4F72-A644-E7C57EB24A0FQ28387248-A4AF9514-9203-474C-A7C1-F898FD1A9BDCQ28394843-BB56EC63-B563-4454-BD8B-33973C7FB27BQ28478066-38E8F1CA-11C1-4908-BE2A-0A2F76569FD3Q28481857-C9CE7BC5-72E6-4E6C-B721-AEFB5085088EQ33947926-1327D9C0-BDA8-4F72-9E00-B89A3CEB0D67Q34981072-B322E83D-1E06-4D5D-8570-DEADA020A876Q35768392-87FE7C3E-CB79-43C5-98D3-14CE03DFC05AQ36303236-A40775A4-C1E2-4B4E-BFAF-22E696B1ADC3Q36364679-2EB82C24-A355-408E-A3F6-4067DBD9CD31Q37137363-9B760894-1699-4027-988A-1CEA37F27D5FQ37186168-D7EE7EE9-C24B-4B79-A266-8CFFE3039BDBQ37316406-5CFC7B88-51CF-456C-B2DB-E88229C21F6BQ37644962-BF992FCB-D9EC-4974-832A-FA0DA070792EQ38220822-9CD13299-5A13-4225-B153-D8F879CB75FCQ38407992-8EE19225-C915-47A3-BD12-527638B82165Q38938545-819DD31E-9999-45C9-BC71-BEDA2F723AF5Q41444937-3C35AD89-3B63-47CB-AF6C-219C83E610CDQ42271492-CAA9BC32-66AF-48FC-A0CE-3FBE2C86481BQ43165459-2C9862F2-65E9-462E-98E6-53EFE3E1EC5DQ47164701-EA37C3DD-AD69-4BD1-9190-53FE18047A4AQ58122179-B961AEB6-D7A8-4142-ADE6-F36E8C8143DB
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Use of nanoparticles for cerebral cancer.
@ast
Use of nanoparticles for cerebral cancer.
@en
Use of nanoparticles for cerebral cancer.
@nl
type
label
Use of nanoparticles for cerebral cancer.
@ast
Use of nanoparticles for cerebral cancer.
@en
Use of nanoparticles for cerebral cancer.
@nl
prefLabel
Use of nanoparticles for cerebral cancer.
@ast
Use of nanoparticles for cerebral cancer.
@en
Use of nanoparticles for cerebral cancer.
@nl
P1433
P1476
Use of nanoparticles for cerebral cancer
@en
P2093
Jörg Kreuter
P304
P356
10.1177/030089160809400220
P577
2008-03-01T00:00:00Z